trending Market Intelligence /marketintelligence/en/news-insights/trending/w_sj5cd9tnded_2awtqwlw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

HLS Therapeutics names CFO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

HLS Therapeutics names CFO

HLS Therapeutics Inc. appointed Tim Hendrickson as CFO, effective Sept. 6.

Hendrickson previously was the company's vice president of finance and administration, a position he has held since 2015.

Toronto-based HLS Therapeutics acquires and distributes in North American markets pharmaceutical products for the central nervous system and cardiovascular specialties.